Summary
Infection is a major threat to patients with neutropenia, particularly those with haematological malignancies who are undergoing chemotherapy. Early use of an empirical antibiotic regimen with the broadest possible spectrum of activity is recommended until culture data can guide the choice. A standard combination in many centres is an aminoglycoside and a semisynthetic penicillin with antipseudomonal activity or a cephalosporin. However, no regimen can adequately cover all potential pathogens and in these patients, who are exposed to many toxic insults, the choice of antibiotics may significantly increase the incidence of side effects, particularly nephrotoxicity. There has, therefore, been considerable interest in simpler, less toxic (and less expensive) regimens and the concept of monotherapy has been explored. Although recent studies using ceftazidime alone have supported this as an effective approach, there remain several issues to resolve; and on a more cautionary note preliminary results from the latest EORTC study, which recruited more than 1200 patients, suggest that in Gram-negative bacteraemia, conventional combination therapy remains the treatment of choice in neutropenia. While monotherapy is attractive in an environment of low drug resistance when exposure to third generation cephalosporins is infrequent, this is rarely the case. In addition, the widespread use of tunnelled catheters for venous access has led to an increase in Gram-positive infections, and the more intensive immunosuppression to the emergence of fungal infections. Although these tend not to be rapidly fatal, their presence must be considered in designing treatment strategies.
The influence of the host and treatment on the type of infection and the relative merits of the differing concepts in therapy are explored in detail in this article.
Similar content being viewed by others
References
Aisner, J.; Murillo, J.; Schimpff, S.C. and Steere, A.C.: Invasive Aspergillus in acute leukaemia: correlation with nose cultures and antibiotic use. Annals of Internal Medicine 90: 4 (1979).
Arnow, P.M.; Chou, T.; Weil, D.; Shapiro, E.N. and Kretzschmar, C.: Nosocomial legionnaires disease caused by aerosolized tap water from respiratory devices. Journal of Infectious Diseases 146: 460 (1982).
Bisno, A.L. and Freeman, J.C.: The syndrome of asplenia, pneumococcal sepsis and disseminated intravascular coagulation. Annals of Internal Medicine 72: 389 (1970).
Bodey, G.P. and Rodriguez, V.: Advances in the management of Pseudomonas aeruginosa infections in cancer patients. European Journal of Cancer 9: 435 (1973).
Bodey, G.P.; Buckley, M.; Sathe, Y.S. and Freireich, E.J.: Quantitative relationship between circulating leucocytes and infection in patients with acute leukaemia. Annals of Internal Medicine 64: 328 (1966).
Bodey, G.P.; Gehan, E.A.; Freireich, E.J. and Frei, E.: Protected environment prophylactic antibiotic program in the chemotherapy of acute leukaemia. American Journal of Medical Science 262: 138 (1971).
Burakoff, S.J.; Lipton, J.M. and Nathan, D.G.: Recapitulation of the immune response and haemopoietic system in bone marrow transplantation; in Nathan (Ed.) Clinics in Haematology p. 695 (W.B. Saunders, London, Philadelphia, Toronto 1983).
Casewell, M. and Phillips, I.: Hands as a route of transmission for Klebsiella species. British Medical Journal 2: 1315 (1977).
Clumeck, N.; van Laethem, Y.; Vanhoff, R.; George, C.; Rapin, M. and Butzler, J.P.: Cefotaxime therapy of serious infections with multiresistant gram negative bacilli. Scandinavian Journal of Infectious Diseases 14: 57 (1982).
Cohen, J.; Donnelly, J.P.; Worsley, A.M.; Catovsky, D.; Goldman, J.M. and Galton, D.A.G.: Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 2: 1452 (1983).
Deeg, J.H.; Storb, R. and Thomas, E.D.: Bone marrow transplantation, a review of delayed complications. British Journal of Haematology 57: 185 (1984).
De Jongh, C.; Joshi, J.; Newman, K.; Danhauer, F.; Finlay, R.; Moody, M.; Wiemik, P. and Schimpff, S.: Moxalactam plus piperacillin or amikacin: empiric antibiotic therapy for febrile neutropenic cancer patients. 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami Beach, Florida (Abstract 943) 1982.
Editorial: Antibiotic-associated colitis — the continuing saga. British Medical Journal 282: 1913 (1981).
Enno, A.; Catovsky, D.; Darrell, J.; Goldman, J.M.; Hows, J. and Galton, D.A.: Co-trimoxazole for preventing infection in acute leukaemia. Lancet 2: 395 (1978).
EORTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 137: 14 (1978).
EORTC International Antimicrobial Therapy Project Group: Combination of Amikacin and Carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. Journal of Clinical Oncology 1: 597 (1983).
EORTC International Antimicrobial Therapy Project Group: Amikacin short or full course plus ceftazidime versus amikacin plus azlocillin for Gram-negative bacteremia in granulocytopenic cancer patients. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 28–October 1, 1986.
Francke, E.L. and Neu, H.C.: Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms. American Journal of Medicine 71: 435 (1981).
Gaya, H.: Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. Schweizerische Medizinische Wochenschrifit 113(Suppl. 14): 49 (1983).
Greenberg, M.S.; Cohen, S.G.; McKitrick, J.C. and Cassileth, P.A.: The oral flora as a source of septicaemia in patients with acute leukaemia. Oral Surgery 53: 32 (1982).
Gribble, M.J.; Chow, A.W.; Naiman, S.C.; Smith, J.A.; Bowie, W.R.; Sacks, S.L.; Grossman, L.; Buskard, N.; Growe, G.H. and Plenderleith, L.H.: Prospective randomised trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrobial Agents and Chemotherapy 24: 388 (1983).
Hann, I.M. and Prentice, H.G.: Infection prophylaxis in the patient with bone marrow failure; in Prentice (Ed.) Clinics in Haematology, p.523 (W.B. Saunders, London, Philadelphia, Toronto 1984).
Hersh, E.M.; Bodey, G.P.; Nies, B.A. and Freireich, E.J.: Causes of death in acute leukaemia. Journal of the American Medical Association 193: 105 (1965).
Hickman, R.O.; Buckner, C.D.; Clift, R.A.; Sanders, J.E.; Stewart, P. and Thomas, E.D.: A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surgery, Gynecology and Obstetrics 148: 871 (1979).
Hosea, S.W.; Burch, C.G.; Brown, E.J.; Berg, R.A. and Frank, M.M.: Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet 1: 804 (1981).
Hughes, W.T.; Kuhn, S.; Chaudhary, S.; Feldman, S.; Verzosa, M.; Aur, R.J.A.; Pratt, C. and George, S.L.: Successful prophylaxis for Pneumocystis carinii pneumonia. New England Journal of Medicine 297: 1419 (1977).
Joshi, J.; Ruxer, R.; Newman, K.; Finlay, R.; Moody, M.R.; Drusano, G.; Tenney, J. and Schimpff, S.: Double beta-lactam versus an aminoglycoside plus beta-lactam combination as empiric therapy for granulocytopenic cancer patients. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C. Abstract 383 (1984).
Klastersky, J.: Therapy with antibiotics in leukaemic patients. Infection 2(Suppl. 2): 97 (1983).
Klastersky, J.; Debusscher, L. and Weerts, D.: Use of oral antibiotics in protected environment unit: clinical effectiveness in the emergence of antibiotic resistant strains. Pathologie et Biologie (Paris) 22: 5 (1974).
Lagast, H.; Meunier-Carpentier, F. and Klastersky, J.: Treatment of gram-negative bacillary septicaemia with cefoperazone. European Journal of Clinical Microbiology 2: 554 (1983).
Levine, A.S.; Siegel, S.E.; Schreiber, A.D.; Hauser, J.; Preisler, H.; Goldstein, I.; Seidler, F.; Simon, R.; Perry, S.; Bennett, J. and Henderson, E.S.: Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukaemia. New England Journal of Medicine 288: 477 (1973).
Levine, A.S.; Schimpff, S.C.; Graw, R.G. and Young, R.C.: Haematological malignancies and other marrow failure states: progress in the management of complicating infections. Seminars in Haematology 11(2): 141 (1974).
Lidwell, O.M. and Towers, A.G.: Unidirectional (‘Laminar’) flow ventilation system for patient isolation. Lancet 1: 347 (1972).
Livermore, D.M.: Mechanisms of resistance to cephalosporin antibiotics. Drugs 34(Suppl. 2): 64 (1987).
Livingston, W.K.; Elliott, A.M.; Dismukes, W.E.; Avent, C.K. and Cobbs, C.G.: Clinical evaluation of moxalactam. Antimicrobial Agents and Chemotherapy 20: 88 (1981).
Love, L.J.; Schimpff, S.C.; Schiffer, C.A. and Wiemik, P.H.: Improved prognosis for granulocytopenic patients with Gram-negative bacteraemia. American Journal of Medicine 68: 643 (1980).
Lowbury, E.J.L.; Babb, J.R. and Ford, P.M.: Protective isolation in a burns unit. Journal of Hygiene 69: 529 (1971).
Lowder, J.N.; Lazarus, HM and Herzig, R.H.: Bacteraemias and fungaemias in oncologic patients with central venous catheters. Archives of Internal Medicine 142: 1456 (1982).
Lowenthal, R.M.; Goldman, J.M.; Buskard, N.A.; Murphy, B.C.; Grossman, L.; Stoning, R.A.; Park, D.S.; Spiers, A.S.D. and Galton, D.A.G.: Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet 1: 352 (1975).
Norrby, S.R.: Side effects of cephalosporins. Drugs 34(Suppl. 2): 105 (1987).
Pennington, J.E.; Reynolds, H.Y. and Carbone, P.P.: Pseudomona pneumonia: a retrospective study of thirty-six cases. American Journal of Medicine 55: 155 (1973).
Pauw, B.E. de; Kauw, F.; Muytjens, H.; Williams, K.J. and Bothof, Th.: Randomized study of ceftazidime versus gentamicin plus cefotaxime for infection in severe granulocytopenic patients. Journal of Antimicrobial Chemotherapy 12(Suppl. A): 93–99 (1983).
Pizzo, P.A.: Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient. Journal of Pediatrics 98: 341 (1981).
Pizzo, P.A.; Hathom, J.W.; Hiemenz, J.: A randomised trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 315: 552 (1986).
Ramphal, R.; Kramer, B.S.; Rand, K.H. and Peeler, D.: A randomised comparison of ceftazidime vs cephalothin, gentamicin, carbenicillin in febrile granulocytopenic cancer patients. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC (Abstract 378) 1984.
Rapson, N.T.; Cornbleet, M.A.; Chessells, J.M.; Bennett, A.J. and Hardisty, R.M.: Immunosuppression and serious infection in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes. British Journal of Haematology 45: 41 (1980).
Remington, J.S. and Schimpff, S.C.: Please don’t eat the salads. New England Journal of Medicine 304: 433 (1981).
Sanders, C.C. and Sanders, W.E. Jr: Microbial resistance to newer generation β-lactam antibiotics: Clinical and laboratory implications. Journal of Infectious Diseases 151: 399 (1985).
Schimpff, S.C.; Young, V.M.; Greene, W.H.; Vermeulen, G.D.; Moody, M.R. and Wiernick, P.H.: Origin of infection in acute non-lymphocytic leukaemias: significance of hospital acquisition of potential pathogens. Annals of Internal Medicine 77: 707 (1972).
Schimpff, S.C.; Greene, W.H.; Young, V.M.; Fortner, C.L.; Jepson, L.; Cusack, N.; Block, J.B. and Wiemik, P.H.: Infection prevention in acute non-lymphocytic leukaemia. Laminar airflow reverse isolation with oral non-absorbable antibiotic prophylaxis. Annals of Internal Medicine 82: 351 (1975).
Sickles, E.A.; Young, V.M.; Greene, W.H. and Wiemik, P.H.: Pneumonia in acute leukaemia. Annals of Internal Medicine 79: 528 (1973).
Siegel, S.E.; Nesbit, M.E.; Baehner, R.; Sather, H. and Hammond, D.: Pneumonia during therapy for children with acute lymphoblastic leukaemia. American Journal of Disease of Children 134: 28 (1980).
Speers, R.; Shooter, R.A.; Gaya, H.; Patel, N. and Hewitt, J.H.: Contamination of nurses’ uniforms with Staphylococcus aureus. Lancet 2: 233 (1969).
Spirer, Z.; Zakuth, V.; Diamant, S.; Mondorf, W.; Stefanescu, T.; Stabinsky, Y. and Fridkin, M.: Decreased tuftsin concentrations in patients who have undergone splenectomy. British Medical Journal 2: 1574 (1977).
Stamm, W.E.; Tompkins, L.S.; Wagner, K.F.; Counts, G.W.; Thomas, E.D. and Meyers, J.D.: Infection due to corynebacterium species in marrow transplant patients. Annals of Internal Medicine 91: 167 (1979).
Stephenson, J.R.; Heard, S.R.; Richards, M.A. and Tabaqchali, S.: Outbreak of septicaemia due to contaminated mouthwash. British Medical Journal 289: 1584 (1984).
Stoning, R.A.; Jamieson, B.; McElwain, T.J.; Wiltshaw, E.; Spiers, A.S.D. and Gaya, H.: Oral nonabsorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet 2: 837 (1977).
Tattersall, M.N.H.; Spiers, A.S.D. and Darrell, J.H.: Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia. Lancet 1: 162 (1972).
Wade, J.C.; Schimpff, S.C.; Newman, K.A. and Wiernik, P.H.: Staphylococcus epidermidis: An increasing cause of infection in patients with granulocytopenia. Annals of Internal Medicine 97: 503 (1982).
Winston, D.J.; Dudnick, D.V.; Chapin, M.; Ho, W.G.; Gale, R.P. and Martin, W.J.: Coagulase-negative staphylococcal bacteraemia in patients receiving immunosuppressive therapy. Archives of Internal Medicine 145: 32 (1983).
Young, L.S.: Management of infections in leukaemia and lymphoma; in Rubin and Young (Eds) Clinical Approach to Infection in the Compromised Host, p.461 (Plenum Press, New York 1981).
Zinner, S.H.: Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Schweizerische Medizinische Wochenschrift 14(Suppl. 14): 7 (1983).
Zinner, S.H.; Klastersky, J.; Gaya, H.; Bernard, C.; Ryff, J.C. and the EORTC Antimicrobial Therapy Project Group: In vitro and in vivo studies of three antibiotic combinations against gram negative bacteria and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 20: 463 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Newland, A.C., Gaya, H. Use of Cephalosporins in the Immunologically Compromised Patient. Drugs 34 (Suppl 2), 205–215 (1987). https://doi.org/10.2165/00003495-198700342-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198700342-00015